当前位置：
X-MOL 学术
›
South. Afr. J. Hiv Med.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Dolutegravir for second-line treatment: Programmatic implications of new evidence.
Southern African Journal of Hiv Medicine ( IF 1.7 ) Pub Date : 2022-09-05 , DOI: 10.4102/sajhivmed.v23i1.1428 Ying Zhao 1, 2 , Gary Maartens 2, 3 , Graeme Meintjes 1, 2
中文翻译：
Dolutegravir 用于二线治疗：新证据的规划意义。
更新日期：2022-09-05
Southern African Journal of Hiv Medicine ( IF 1.7 ) Pub Date : 2022-09-05 , DOI: 10.4102/sajhivmed.v23i1.1428 Ying Zhao 1, 2 , Gary Maartens 2, 3 , Graeme Meintjes 1, 2
Affiliation
中文翻译：
Dolutegravir 用于二线治疗：新证据的规划意义。
京公网安备 11010802027423号